Download MendeleyA Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization.
Singh, T., Hwang, K.K., Miller, A.S., Jones, R.L., Lopez, C.A., Dulson, S.J., Giuberti, C., Gladden, M.A., Miller, I., Webster, H.S., Eudailey, J.A., Luo, K., Von Holle, T., Edwards, R.J., Valencia, S., Burgomaster, K.E., Zhang, S., Mangold, J.F., Tu, J.J., Dennis, M., Alam, S.M., Premkumar, L., Dietze, R., Pierson, T.C., Ooi, E.E., Lazear, H.M., Kuhn, R.J., Permar, S.R., Bonsignori, M.(2022) Cell 185: 4826-4840.e17
- PubMed: 36402135 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1016/j.cell.2022.10.023
- Primary Citation Related Structures:
7T17 - PubMed Abstract:
Congenital Zika virus (ZIKV) infection results in neurodevelopmental deficits in up to 14% of infants born to ZIKV-infected mothers. Neutralizing antibodies are a critical component of protective immunity. Here, we demonstrate that plasma IgM contributes to ZIKV immunity in pregnancy, mediating neutralization up to 3 months post-symptoms. From a ZIKV-infected pregnant woman, we isolated a pentameric ZIKV-specific IgM (DH1017.IgM) that exhibited ultrapotent ZIKV neutralization dependent on the IgM isotype. DH1017.IgM targets an envelope dimer epitope within domain II. The epitope arrangement on the virion is compatible with concurrent engagement of all ten antigen-binding sites of DH1017.IgM, a solution not available to IgG. DH1017.IgM protected mice against viremia upon lethal ZIKV challenge more efficiently than when expressed as an IgG. Our findings identify a role for antibodies of the IgM isotype in protection against ZIKV and posit DH1017.IgM as a safe and effective candidate immunotherapeutic, particularly during pregnancy.
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94709, USA.
Organizational Affiliation:
